Back to Results
First PageMeta Content
Glycosaminoglycans / Oral and maxillofacial surgery / Oral surgery / Restylane / Hyaluronan / Lip enhancement / Adverse event / Food and Drug Administration / Medical device / Medicine / Clinical research / Pharmaceutical industry


Microsoft Word - Executive Summary-FDA-Final.doc
Add to Reading List

Open Document

File Size: 208,12 KB

Share Result on Facebook
UPDATE